Calliditas Therapeutics AB (Calliditas Therapeutics AB) Change In Inventory

: $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

Calliditas Therapeutics AB's change in inventory for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Calliditas Therapeutics AB's inventory stayed the same from Sep. 2023 to Dec. 2023 .

Calliditas Therapeutics AB's change in inventory for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Calliditas Therapeutics AB's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Calliditas Therapeutics AB's Total Inventories for the quarter that ended in Dec. 2023 was $1.99 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Calliditas Therapeutics AB's Days Inventory for the quarter that ended in Dec. 2023 was 72.09.

Inventory Turnover measures how fast the company turns over its inventory within a year. Calliditas Therapeutics AB's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.27.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Calliditas Therapeutics AB's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.04.

Calliditas Therapeutics AB Change In Inventory Historical Data

The historical data trend for Calliditas Therapeutics AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-0.10

-0.27

Calliditas Therapeutics AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Calliditas Therapeutics AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Calliditas Therapeutics AB (NAS:CALT) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Calliditas Therapeutics AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1.7175	/	2.174	*	365 / 4
	=	72.09

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Calliditas Therapeutics AB's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.174	/	1.7175
	=	1.27

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Calliditas Therapeutics AB's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.7175	/	44.022
	=	0.04

Calliditas Therapeutics AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Calliditas Therapeutics AB (Calliditas Therapeutics AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (NAS:CALT) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

CALTX:Sweden CALTXs:UK LC8:Germany

Address

Kungsbron 1, D5, Stockholm, SWE, SE-111 22

Website

https://www.calliditas.se

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.